Leukemia Cutis in Acute Myeloid Leukemia Signifies a Poor ...
Part 4 Acute Myeloid Leukemia
-
Upload
md-specialclass -
Category
Health & Medicine
-
view
1.440 -
download
5
Transcript of Part 4 Acute Myeloid Leukemia
![Page 1: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/1.jpg)
Myeloid NeoplasmMALIGNANT NEOPLASM OF
HEMATOPOIETIC STEM CELLS ARISE
PRIMARILY IN BONE MARROWALSO SPLEEN, LIVER, LN - To a Lesser
ExtentFLOOD THE CIRCULATING BLOOD
& OTHER ORGANS
![Page 2: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/2.jpg)
3 Broad Categories of Myeloid Neoplasm
1. Acute MyelogenousImmature progenitor cells accumulate in BM
2. Myelodysplastic SyndromesIneffective HematopoiesisPeripheral Cytopenias
![Page 3: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/3.jpg)
3 Broad Categories of Myeloid Neoplasm
3. Chronic Myeloproliferative D/OIncreased production1 or more terminally differentiated
myeloid elementsGRANULOCYTES
Leads to elevated peripheral blood counts
TYPES: CML, Polycthemia vera, Essential
thrombocytosis, primary myelofibrosis
![Page 4: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/4.jpg)
ACUTE MYELOID LEUKEMIA
![Page 5: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/5.jpg)
FeaturesAffects primarily Adults
15 – 39 y/o peak incidenceAcute Onset of symptoms R/T
AnemiaNeutropenia - InfectionsSpontaneous mucosal & cutaneous Bleeding
Bleeding diasthesis is most striking feature
![Page 6: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/6.jpg)
FeaturesEnlargement of liver, spleenLN enlargement is not pronouncedIf untreated, course is rapidly
progressive
![Page 7: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/7.jpg)
![Page 8: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/8.jpg)
PATHOPHYSIOLOGY1. MOSTLY WITH ACQUIRED GENETIC
ALTERATIONS INHIBITION OF TERMINAL MYELOID
DIFFERENTIATIONProliferation of Relatively Undifferentiated
MyeloblastREPLACED NORMAL MARROW ELEMENTSIts replication rate is LOWER than normal
myeloid cellsINDICATING :1. BLOCKED MATURATION2. INCREASED SURVIVAL
![Page 9: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/9.jpg)
2. Chromosomal Abnormalities- AML t(8;21) , inv(16) , t(15,17)De Novo casesAssociated with Myelodysplastic syndromes
Radiation therapy
PATHOPHYSIOLOGY
![Page 10: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/10.jpg)
PATHOPHYSIOLOGYRecurrent Chromosomal Aberrations
Translocation Disrupt genes encoding for Factors needed for NORMAL MYELOID DIFFERENTIATION
Eg. t(8,21) AND inv(16) Chimeric gene New Protein Dominant Negative activity Daughter cells exhibit partial or complete block in terminal differentiation
![Page 11: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/11.jpg)
Additional Collaborative Aberration present Promyelocytic Leukemia (AML-M3)
T(15,17) producing fusion gene RAR aand PMLSuppress the function of RAR a Becomes a Repressor of Transcription Turns off genes needed for full and complete myeloid differentiation
Point mutation in FLT3 constitutive activation of tyrosine kinase promote cellular proliferation & survival
![Page 12: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/12.jpg)
Diagnosis:Dx requires at least 30% of ANC are Myeloblast (ANC- all nucleated cells )WHO criteria
Been lowered to 20% With elimination of of MDS
Refractory anemia w/ excess blastBlast in Transformation
Helpful in the dx is (+) Auer rods in myeloblast cells
![Page 13: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/13.jpg)
Myeloblast
![Page 14: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/14.jpg)
Myeloperoxidase
SBB
Esterase
![Page 15: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/15.jpg)
AUER RODSLinear or SpindleRed- Purple InclusionsIn Myeloblast/myelocyteDerivatives of Azurophilic granulesStain (+) SBB, MPO, ACPEspecially associated w/ M1 to M3
![Page 16: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/16.jpg)
MO Minimally Differentited
AML
2-3 % Blast lack definitive cytologic & Cytochemical markers of myeloblast
M1 AML w/o Differentiation
20 % Very immature > 3% blast (+) peroxidase, Few Auer Rods, Little Maturation beyond blast stage
M2 AML with maturation
30-40%Full range of myeloid Differentiation. Auer rods (+) in most cases. Often associated w/ t(8,21)
M3 Acute Promyelocytic
Leukemia
5-10% Most are Hypergranular promyeloctes, Often many Auer rods per cell, ( 35-40y/o ), DIC, t( 15;17 )
Revised Classification of AML
![Page 17: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/17.jpg)
M4 Acute Myelomonocytic Leukemia
15-20%
Myeloid elements show wide range of differentiationMonoblast (+) NSE Non-specific EsteraseSubset assoc. w/ Inv. (16)
M5 Acute Monocytic Leukemia
10% Older Patients, High incidence of Organomegaly,Lymphadenopathy & Tissue Infiltrationa. Monoblast & Promonocytes Predominates BM & Bloodb. Mature Monocytes predominate Blood
M6 Acute Erythroleukemia
5% Seen in Advanced Age
M7 Acute Megakaryocytic Leukemia
1% Myelofibrosis seen in most cases
![Page 18: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/18.jpg)
![Page 19: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/19.jpg)
M6 ErythroleukemiaErythroid precursor predominatesBlast are also IncreasedDx when > 50% of BM cells are
erythroid precursors and Myeloblast represent > 30% of Non-Erythroid cells
M7 Megakaryoblast are identified by Ab
against Platelet-associated Antigens
![Page 20: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/20.jpg)
FACTOR FAVORABLE UNFAVORABLE
AGE <45 yrs <2 YRS, >60 yrs
LEUKOCYTOSIS <25 d >100D
CNS ABSENT PRESENT
RESPONSE TO TX RAPID DELAYED/INCOMPLETE
AUER RODS PRESENT ABSENT
FAB TYPE M2,M3, M4EO M5,M6,M7
CELLMARKERS CD2 /CD19 CD13/CD14/CD33
![Page 21: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/21.jpg)
TREATMENT / PROGNOSISWith ChemoTx
60% Complete remission15-30% remain free from disease for 5 yearst(8;21) , inv(16)
Relative good response to chemoTx Allogenic BM therapy
High risk forms AML Develop from myelodysplastic syndromeRelapse AML
![Page 22: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/22.jpg)
Vit A derivativeOvercome the block in differentiation r/t
t(15,17) and presence of RAR PML fusion protein
Ultimately relapses when used aloneFail to prevent self-renewal of neoplastic
progenitor cells
TREATMENT / PROGNOSIS
![Page 23: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/23.jpg)
Difference of AML & ALLFEATURES/
MxAML ALL
TISSUE INFILTRATION
LESS STRIKINGM4M5- Leukemia cutis/ Gingival infiltrates
MORE COMMON
CNS INVOLVEMENT
LESS MORE COMMON
LYMPHADENOPATHY
LESS MORE COMMON
![Page 24: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/24.jpg)
M1- Blast cells are minimally differentiated Express CD 34 (marker of multipotent stem cells )Negative for CD 64 ( marker of mature myeloid cells )(+) CD33 ( marker for immature myeloid cellsSubset (+) CD 15 ( marker for more mature myeloid cell
AML-M1
![Page 25: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/25.jpg)
Acute Myeloblastic Leukemia w/ Maturation M2
Myeloblast represent 20% (WHO) to 89% of total marrow cells
> 10% of NEC are promyelocyte to neutrophils
Auer rods are usually present –mulitple
![Page 26: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/26.jpg)
ACUTE PROMYELOCYTIC LEUKEMIA M3(35-40y/o)
Promyelocytespredominate
Azurophilic granulesabundant & stain
intenselyHypergranular promyelocytes
Auer rods almost always (+) , multiple or clusters
Hemorrhagic complications frequent due to DIC Initiated by PROCOAGULANT
materials from Leukemic cell Granules
![Page 27: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/27.jpg)
ACUTE MONOCYTIC LEUKEMIA M5Promyelocytes and BlastGum Infiltrates2 types
Poorly Differentiated M5A LARGE BLAST >80% OF MARROW MONOCYTIC CELLS
Differentiated M5B FEWER MONOBLAST < 80% OF MARROW MONOCYTIC CELLS MORE PROMONOCYTES & MONOCYTES
![Page 28: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/28.jpg)
ERYTHROLEUKEMIA M6Erythroblast predominates Myeloblast are also Increased
> 50% NC of BM are Erythroblast>20% (WHO) of NEC are Myeloblast
![Page 29: Part 4 Acute Myeloid Leukemia](https://reader035.fdocuments.us/reader035/viewer/2022062220/5560e087d8b42afb7b8b48cf/html5/thumbnails/29.jpg)
MEGAKARYOCYTIC M7Undifferentiated BlastMegakaryoblast identified by Ab against Platelet
associated antigensMarrow Fibrosis